Diabetic neuropathy: scope of the syndrome (Q33731674)

29 July 2017

1 reference

title

Diabetic neuropathy: scope of the syndrome (English)

1 reference

29 July 2017

1 reference

Greene DA

1

1 reference

29 July 2017

Stevens MJ

series ordinal

2

1 reference

29 July 2017

Feldman EL

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

American Journal of Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

107

1 reference

29 July 2017

issue

2B

1 reference

29 July 2017

page(s)

2S-8S

1 reference

Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

The role of endogenous nerve growth factor in human diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

The natural history of painful diabetic neuropathy--a 4-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

The natural history of acute painful neuropathy in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Diabetic truncal neuropathy: topography of the sensory deficit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Prevalence of diabetic autonomic neuropathy measured by simple bedside tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Autonomic neuropathy and diabetic foot ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Living with water stress: evolution of osmolyte systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Sorbitol, osmoregulation, and the complications of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Osmoregulatory fluxes of myo-inositol and betaine in renal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Complications: neuropathy, pathogenetic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Local human sural nerve blood flow in diabetic and other polyneuropathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Metabolism of fructose-3-phosphate in the diabetic rat lens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

The Roles of Oxidative Stress and Antioxidant Treatment in Experimental Diabetic Neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Diabetic neuropathy, nerve growth factor and other neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Nerve growth factor administration protects against experimental diabetic sensory neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Nerve growth factor and oxidative stress in the nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900007-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00007-8

1 reference

29 July 2017

1 reference